Empowering Tomorrow’s Therapies:
AI-Driven Solutions for Antimicrobial Resistance

Automating drug discovery to build better antimicrobials for the antimicrobial resistance today, tomorrow, and beyond.

Driving Technology

Bioinformatics Pipelines & Simulations

Bioinformatics pipelines that extract the most information out of sequencing data that is available. Our bioinformatics simulations can simulate in vitro lab tests and generational testing.
Advanced AI and Machine Learning

Our artificial intelligence and machine learning algorithms are built to provide insight into how pathogens interact with drugs. They can predict potency for pathogens and antimicrobials that exist now, tomorrow, and in the future.
Unique and Diverse Dataset

Our systems are built and validated using a broad and diverse dataset, allowing us to predict for vast amounts of species and types of compounds.

How our technology can drive innovation

Future Resistance

Be able to predict how pathogen will react to your treatment and develop new resistant mutations.

Future Therapies

Use the future antimicrobial resistance predictions to develop and test new therapeutic compounds now. Our technology can help develop and provide new compounds and augmentations to current compounds to treat those future mutations.

Direct Potency

Our technology can predict direct potency of a drug against a specific pathogen in silico. This allows for numerous potency tests to be performed all at once, saving on days or weeks of effort and cost when compared to standard lab tests.

Meet our team